Atrion Corporation (ATRI)
NASDAQ: ATRI · IEX Real-Time Price · USD
457.00
+0.42 (0.09%)
At close: Jul 19, 2024, 4:00 PM
456.88
-0.12 (-0.03%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Atrion Revenue

Atrion had revenue of $176.67M in the twelve months ending March 31, 2024, with 0.17% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $47.33M with 18.36% year-over-year growth. In the year 2023, Atrion had annual revenue of $169.33M.

Revenue (ttm)
$176.67M
Revenue Growth
+0.17%
P/S Ratio
4.55
Revenue / Employee
$248,128
Employees
712
Market Cap
804.30M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023169.33M-14.18M-7.73%
Dec 31, 2022183.51M18.50M11.21%
Dec 31, 2021165.01M17.42M11.80%
Dec 31, 2020147.59M-7.48M-4.82%
Dec 31, 2019155.07M2.62M1.72%
Dec 31, 2018152.45M5.85M3.99%
Dec 31, 2017146.60M3.11M2.17%
Dec 31, 2016143.49M-2.25M-1.54%
Dec 31, 2015145.73M4.97M3.53%
Dec 31, 2014140.76M8.77M6.64%
Dec 31, 2013131.99M12.93M10.86%
Dec 31, 2012119.06M1.36M1.15%
Dec 31, 2011117.70M9.14M8.41%
Dec 31, 2010108.57M7.93M7.88%
Dec 31, 2009100.64M4.75M4.95%
Dec 31, 200895.90M7.36M8.31%
Dec 31, 200788.54M7.52M9.28%
Dec 31, 200681.02M8.93M12.39%
Dec 31, 200572.09M6.01M9.09%
Dec 31, 200466.08M3.28M5.22%
Dec 31, 200362.80M3.27M5.49%
Dec 31, 200259.53M1.93M3.35%
Dec 31, 200157.61M6.16M11.97%
Dec 31, 200051.45M1.53M3.07%
Dec 31, 199949.92M6.52M15.02%
Dec 31, 199843.40M13.12M43.33%
Dec 31, 199730.28M8.16M36.87%
Dec 31, 199622.12M10.40M88.76%
Dec 31, 199511.72M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Pennant Group 575.34M
Aurinia Pharmaceuticals 191.41M
Standard BioTools 126.76M
Simulations Plus 66.98M
CureVac 64.13M
Abivax 5.13M
Revenue Rankings